Medical - Healthcare Information Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
FORA vs VRNT vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Banks - Diversified
FORA vs VRNT vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Software - Infrastructure | Banks - Diversified |
| Market Cap | $68M | $1.24B | $908.57B |
| Revenue (TTM) | $30M | $894M | $280.33B |
| Net Income (TTM) | $-5M | $61M | $57.05B |
| Gross Margin | 46.8% | 69.9% | 60.0% |
| Operating Margin | -13.4% | 8.6% | 25.9% |
| Forward P/E | — | 7.0x | 14.6x |
| Total Debt | $12K | $448M | $942.38B |
| Cash & Equiv. | $13M | $216M | $343.34B |
FORA vs VRNT vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Forian Inc. (FORA) | 100 | 21.5 | -78.5% |
| Verint Systems Inc. (VRNT) | 100 | 44.6 | -55.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 205.8 | +105.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORA vs VRNT vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FORA is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
- Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
- Beta 0.21, current ratio 2.97x
VRNT has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 0.36 vs JPM's 0.83
- Lower P/E (7.0x vs 14.6x), PEG 0.36 vs 0.83
- +24.8% vs FORA's +2.4%
JPM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.87, yield 1.8%
- 481.2% 10Y total return vs VRNT's -41.6%
- 20.4% margin vs FORA's -17.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 50.1% revenue growth vs VRNT's -0.1% | |
| Value | Lower P/E (7.0x vs 14.6x), PEG 0.36 vs 0.83 | |
| Quality / Margins | 20.4% margin vs FORA's -17.0% | |
| Stability / Safety | Beta 0.21 vs VRNT's 1.02, lower leverage | |
| Dividends | 1.8% yield, 15-year raise streak, vs VRNT's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +24.8% vs FORA's +2.4% | |
| Efficiency (ROA) | 2.8% ROA vs FORA's -11.8%, ROIC 5.3% vs -7.5% |
FORA vs VRNT vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FORA vs VRNT vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 9328.3x FORA's $30M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to FORA's -17.0%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $30M | $894M | $280.3B |
| EBITDAEarnings before interest/tax | -$4M | $127M | $81.4B |
| Net IncomeAfter-tax profit | -$5M | $61M | $57.0B |
| Free Cash FlowCash after capex | $2M | $118M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +46.8% | +69.9% | +60.0% |
| Operating MarginEBIT ÷ Revenue | -13.4% | +8.6% | +25.9% |
| Net MarginNet income ÷ Revenue | -17.0% | +6.9% | +20.4% |
| FCF MarginFCF ÷ Revenue | +7.8% | +13.2% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.9% | -1.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -2.0% | -5.1% | +16.0% |
Valuation Metrics
VRNT leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 16.2x trailing earnings, JPM trades at a 18% valuation discount to VRNT's 19.7x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs VRNT's 1.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $68M | $1.2B | $908.6B |
| Enterprise ValueMkt cap + debt − cash | $55M | $1.5B | $1.51T |
| Trailing P/EPrice ÷ TTM EPS | -23.48x | 19.72x | 16.22x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.00x | 14.60x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x | 0.92x |
| EV / EBITDAEnterprise value multiple | — | 9.46x | 18.52x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 1.37x | 3.25x |
| Price / BookPrice ÷ Book value/share | 2.27x | 0.97x | 2.51x |
| Price / FCFMarket cap ÷ FCF | 23.49x | 8.75x | 9.01x |
Profitability & Efficiency
VRNT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), VRNT scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +4.6% | +15.9% |
| ROA (TTM)Return on assets | -11.8% | +2.8% | +1.3% |
| ROICReturn on invested capital | -7.5% | +5.3% | +4.5% |
| ROCEReturn on capital employed | -8.2% | +5.9% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.34x | 2.60x |
| Net DebtTotal debt minus cash | -$13M | $233M | $599.0B |
| Cash & Equiv.Liquid assets | $13M | $216M | $343.3B |
| Total DebtShort + long-term debt | $12,137 | $448M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | -48.78x | 8.24x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, VRNT leads with a +24.8% total return vs FORA's +2.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs VRNT's -17.6% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | — | +0.8% |
| 1-Year ReturnPast 12 months | +2.4% | +24.8% | +20.9% |
| 3-Year ReturnCumulative with dividends | -7.3% | -44.1% | +138.8% |
| 5-Year ReturnCumulative with dividends | -82.7% | -54.4% | +135.5% |
| 10-Year ReturnCumulative with dividends | -90.5% | -41.6% | +481.2% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -17.6% | +33.7% |
Risk & Volatility
Evenly matched — FORA and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
FORA is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than VRNT's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs FORA's 80.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 1.02x | 0.87x |
| 52-Week HighHighest price in past year | $2.71 | $22.84 | $338.09 |
| 52-Week LowLowest price in past year | $1.64 | $16.23 | $269.72 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +89.8% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 68.4 | 72.1 |
| Avg Volume (50D)Average daily shares traded | 40K | 0 | 7.4M |
Analyst Outlook
JPM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRNT as "Hold", JPM as "Buy". Consensus price targets imply 58.8% upside for VRNT (target: $33) vs 4.5% for JPM (target: $340). For income investors, JPM offers the higher dividend yield at 1.83% vs VRNT's 1.56%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy |
| Price TargetConsensus 12-month target | — | $32.57 | $339.75 |
| # AnalystsCovering analysts | — | 16 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +1.6% | +1.8% |
| Dividend StreakConsecutive years of raises | — | 0 | 15 |
| Dividend / ShareAnnual DPS | — | $0.32 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +5.8% | +3.8% |
JPM leads in 3 of 6 categories (Income & Cash Flow, Total Returns). VRNT leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
FORA vs VRNT vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORA or VRNT or JPM a better buy right now?
For growth investors, Forian Inc.
(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus -0. 1% for Verint Systems Inc. (VRNT). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORA or VRNT or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 2x versus Verint Systems Inc. at 19. 7x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Verint Systems Inc. wins at 0. 36x versus JPMorgan Chase & Co. 's 0. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FORA or VRNT or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORA or VRNT or JPM?
By beta (market sensitivity over 5 years), Forian Inc.
(FORA) is the lower-risk stock at 0. 21β versus Verint Systems Inc. 's 1. 02β — meaning VRNT is approximately 388% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORA or VRNT or JPM?
By revenue growth (latest reported year), Forian Inc.
(FORA) is pulling ahead at 50. 1% versus -0. 1% for Verint Systems Inc. (VRNT). On earnings-per-share growth, the picture is similar: Verint Systems Inc. grew EPS 271. 4% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORA or VRNT or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -9. 5% for Forian Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -8. 2% for FORA. At the gross margin level — before operating expenses — VRNT leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORA or VRNT or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Verint Systems Inc. (VRNT) is the more undervalued stock at a PEG of 0. 36x versus JPMorgan Chase & Co. 's 0. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verint Systems Inc. (VRNT) trades at 7. 0x forward P/E versus 14. 6x for JPMorgan Chase & Co. — 7. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRNT: 58. 8% to $32. 57.
08Which pays a better dividend — FORA or VRNT or JPM?
In this comparison, JPM (1.
8% yield), VRNT (1. 6% yield) pay a dividend. FORA does not pay a meaningful dividend and should not be held primarily for income.
09Is FORA or VRNT or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). Both have compounded well over 10 years (JPM: +481. 2%, VRNT: -41. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORA and VRNT and JPM?
These companies operate in different sectors (FORA (Healthcare) and VRNT (Technology) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORA is a small-cap high-growth stock; VRNT is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. VRNT, JPM pay a dividend while FORA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.